Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Total 13F shares
-
179,167,298
-
Share change
-
+1,611,429
-
Total reported value
-
$14,847,543,178
-
Put/Call ratio
-
134%
-
Price per share
-
$82.87
-
Number of holders
-
525
-
Value change
-
+$141,628,422
-
Number of buys
-
241
-
Number of sells
-
261
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2022
As of 30 Jun 2022 BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) had 525 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 179,167,298 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, Dodge & Cox, BlackRock Inc., BAKER BROS. ADVISORS LP, AMERIPRISE FINANCIAL INC, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, Capital Research Global Investors, and JANUS HENDERSON GROUP PLC.
This table shows 525 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.